7 completed, 1 unknown. 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 7, Unknown 1 |
Follow Pneumonia, Pneumococcal: new trials by email Literature Review of Pneumonia, Pneumococcal trials Research Report on Pneumonia, Pneumococcal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly With Influenza Vaccine in Adults 50 Years of Age or Older (V116-005, STRIDE-5) V116, QIV, Matching Placebo for V116 - Pneumonia, Pneumococcal | Phase 3 | Completed | Merck Sharp & Dohme LLC | 1080 | 2022-09-23 | 2025-10-29 |
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6) V116, PCV15, PPSV23 - Pneumonia, Pneumococcal | Phase 3 | Completed | Merck Sharp & Dohme LLC | 717 | 2022-07-12 | 2024-10-26 |
| Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers 15-Valent Pneumococcal Conjugate Vaccine, 13-Valent Pneumococcal Conjugate Vaccine - Pneumonia, Pneumococcal | Phase 3 | Unknown | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 1950 | 2020-07-01 | 2020-04-22 |
| Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants Pneumosil, Prevenar 13, Synflorix - Pneumonia, Pneumococcal | Phase 3 | Completed | PATH | 660 | 2019-07-18 | 2022-04-20 |
| Lot-to-Lot Consistency of V114 in Healthy Adults (V114-020) V114, Prevnar 13™ - Pneumococcal Infections, Pneumonia, Pneumococcal | Phase 3 | Completed | Merck Sharp & Dohme LLC | 2340 | 2019-06-12 | 2021-04-12 |
| Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and Above 23-Valent Pneumococcal Polysaccharide Vaccine - Pneumonia, Pneumococcal | Phase 3 | Completed | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 1940 | 2018-01-12 | 2020-02-20 |
| Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants Pneumosil, Synflorix - Pneumonia, Pneumococcal | Phase 3 | Completed | PATH | 2250 | 2017-06-21 | 2020-07-14 |
| New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia) Antibiotic - Pneumonia, Pneumococcal, Community Acquired Infections | Phase 3 | Completed | Pfizer | 230 | 2001-12-01 | 2011-04-26 |
Community-Acquired Infections (1) · Gram-Positive Bacterial Infections (1) · Pneumococcal Infections (1)
Bacterial Infections (8) · Bacterial Infections and Mycoses (8) · Infections (8) · Lung Diseases (8) · Pneumonia (8) · Pneumonia, Bacterial (8) · Respiratory Tract Diseases (8) · Respiratory Tract Infections (8) · Streptococcal Infections (8) · Gram-Positive Bacterial Infections (7) · Pneumococcal Infections (7)
13-valent pneumococcal vaccine (2) · 23-valent pneumococcal capsular polysaccharide vaccine (2) · PHiD-CV vaccine (2) · Anti-Bacterial Agents (1)
Merck Sharp & Dohme LLC (3) · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (2) · PATH (2) · Pfizer (1)
United States (4) · China (2) · Spain (2) · Taiwan (2) · The Gambia (2) · Australia (1) · Canada (1) · Chile (1) · Denmark (1) · Finland (1) · France (1) · Israel (1) · Italy (1) · Japan (1) · Slovakia (1)
Du Lin, Master (2) · Ed Clarke (1) · Ed Clarke, MB ChB, PhD (1)
PMID 33516293, PMID 35039194, PMID 36638819, PMID 39082735, PMID 40714528
2018 (1)